A detailed history of Bessemer Group Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 30 shares of TMDX stock, worth $2,427. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Holding current value
$2,427
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$135.68 - $176.11 $4,070 - $5,283
30 New
30 $5,000
Q4 2020

Feb 09, 2021

SELL
$11.91 - $19.9 $4,764 - $7,959
-400 Reduced 22.22%
1,400 $28,000
Q3 2020

Nov 12, 2020

SELL
$13.78 - $18.84 $12,402 - $16,956
-900 Reduced 33.33%
1,800 $25,000
Q2 2020

Aug 05, 2020

BUY
$11.66 - $18.26 $31,482 - $49,302
2,700 New
2,700 $48,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.58B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.